Intriguingly, loss-of-function mutations in SPG11 (6–9), ZFYVE26 (SPG15) (10,11) and AP5Z1 [SPG48 (3,12–14)] have all been described in patients with hereditary spastic paraplegia (HSP). Here, SPG11 is linked to hereditary spastic paraplegia.